Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.45 USD | +0.73% | +0.13% | +8.40% |
Evolution of the average Target Price on Royalty Pharma plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Royalty Pharma plc
JPMorgan Chase | |
Goldman Sachs | |
Morgan Stanley | |
UBS | |
Citigroup | |
Tigress Financial | |
Scotiabank |
EPS Revisions
- Stock
- Equities
- Stock Royalty Pharma plc - Nasdaq
- Consensus Royalty Pharma plc